Feature|Videos|January 8, 2024
AstraZeneca Vice President, Head of Breast Cancer Franchise, Discusses Impact of Truqap Approval
Author(s)Don Tracy, Associate Editor
In an interview with Pharmaceutical Executive associate editor Don Tracy, Ashley Gaines, VP, head of breast cancer franchise, discusses newly approved Truqap.
Advertisement
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
AstraZeneca Stock Becomes UK’s Biggest Stock
2
Pfizer’s Proven Playbook: Buy, Partner, Scale, Spin-Off, Optimize
3
HHS and FDA Appoint Richard Pazdur as Director of The Center for Drug Evaluation and Research
4
Basel, Switzerland, Puts Out Call for Pharma Execs
5
